Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 1.550
-0.025 (-1.59%)
Oct 27, 2026, 4:18 PM AEDT
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 578.28 million as of October 27, 2026. It is the 15,808th most valuable company in the world and the 300th biggest in Australia. Its market cap has decreased by 65.53% in one year.
Market Cap
578.28M
Enterprise Value
400.02M
Revenue
10.53M
Global Rank
Country Rank
#300 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 578.28M, an increase of 50.51%. That is a compound annual growth rate of 8.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 578.28M | -54.01% |
| Dec 31, 2025 | 1.26B | -6.00% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 2.36B |
| Mesoblast | 2.32B |
| PYC Therapeutics | 1.73B |
| Clinuvel Pharmaceuticals | 353.50M |
| Racura Oncology | 322.53M |
| Tetratherix | 272.19M |
| Starpharma Holdings | 227.88M |
| BLS Pharmaceuticals | 218.79M |